Literature DB >> 21817918

A coincidence of addiction to "Kratom" and severe primary hypothyroidism.

Sergey V Sheleg1, Gregory B Collins.   

Abstract

Here we present a case of a coincidence of addiction to "Kratom" (botanically known as Mitragyna speciosa Korth) and developed severe primary hypothyroidism. We are discussing a possibility that high dose of indole alkaloid mitragynine (the major alkaloid identified from "Kratom") might reduce the normal response of the thyroid gland to thyroid-stimulating hormone resulting in primary hypothyroidism. Further experimental investigations of mitragynine as a possible suppressor of thyroid gland function would be a matter of interest.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21817918     DOI: 10.1097/ADM.0b013e318221fbfa

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  17 in total

Review 1.  Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Authors:  Christopher D Rosenbaum; Stephanie P Carreiro; Kavita M Babu
Journal:  J Med Toxicol       Date:  2012-03

2.  The Right to Use Kratom from the Psychiatric and Islamic Perspectives.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Mohd Afifuddin Mohamad; Noor Naemah Abdul Rahman
Journal:  J Relig Health       Date:  2021-04

3.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

4.  Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.

Authors:  Anne-Christin Stolt; Helmut Schröder; Hartmud Neurath; Gisela Grecksch; Volker Höllt; Markus R Meyer; Hans H Maurer; Nancy Ziebolz; Ursula Havemann-Reinecke; Axel Becker
Journal:  Psychopharmacology (Berl)       Date:  2013-07-12       Impact factor: 4.530

5.  Pharmacokinetics of mitragynine in man.

Authors:  Satariya Trakulsrichai; Korbtham Sathirakul; Saranya Auparakkitanon; Jatupon Krongvorakul; Jetjamnong Sueajai; Nantida Noumjad; Chonlaphat Sukasem; Winai Wananukul
Journal:  Drug Des Devel Ther       Date:  2015-04-29       Impact factor: 4.162

6.  Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report.

Authors:  Lauren LaBryer; Rohan Sharma; Kaustubh Suresh Chaudhari; Mitali Talsania; Robert Hal Scofield
Journal:  J Investig Med High Impact Case Rep       Date:  2018-03-16

Review 7.  Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom.

Authors:  Dimy Fluyau; Neelambika Revadigar
Journal:  Front Psychiatry       Date:  2017-04-24       Impact factor: 4.157

8.  Kratom instrumentalization for severe pain self-treatment resulting in addiction - A case report of acute and chronic subjective effects.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2020-07-21

9.  Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.

Authors:  Alicia G Lydecker; Abhisheak Sharma; Christopher R McCurdy; Bonnie A Avery; Kavita M Babu; Edward W Boyer
Journal:  J Med Toxicol       Date:  2016-10-17

Review 10.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.